REDUCED EXPRESSION OF HLA CLASS-I AND CLASS-II ANTIGENS IN COLON CANCER
- 15 December 1990
- journal article
- research article
- Vol. 50 (24) , 8023-8027
Abstract
The expression of HLA class I and II antigens was studied by immunohistochemistry in (a) specimens of colon cancer from 25 patients, (b)n ormal colonic mucosa obtained 5-10 cm away from each tumor, and (c) colonic mucosa from 13 normal individuals. Thirteen of the tumor specimens had normal epithelium adjacent to the cancer, which thus served as an internal control. The expression of HLA class I antigens in colon cancer was dramatically reduced compared to control (P < 0.0001): undetectable in 28%, diminished in 68%, normal in 4%. The expression of class II antigens was also reduced in cancer (P < 0.0001 for all when compared to normal), being undetectable in most (HLA-DP 64%, HLA-DQ 72%, HLA-DR 68%). In 44% of the cancers all three HLA class II antigens were undetectable; in 92% at lest one class II antigen was undectable; and in 20% both class I and class II antigens were undetectable. No cancer specimen had a completely normal HLA phenotype. The expression of other surface antigens was preserved in cancer tissues and, therefore, loss of HLA antigens was not due to a nonspecific decline in surface molecules. when glands of normal mucosa immediately adjacent to cancer were compared to those of normal controls, significantly reduced expression of only HLA class I antigens (P = 0.0149) and HLA-DP (P = 0.034) was found. The expression of the HLA antigens in colonic mucosa remote from the cancer was no different from that of normal controls. Our data show extensive and significant eduction in the expression of HLA antigens in colon cancer; its potential relationship to immmunosurveillance in cancer is discussed.This publication has 10 references indexed in Scilit:
- Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.Proceedings of the National Academy of Sciences, 1989
- Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.The Journal of Experimental Medicine, 1989
- Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.Proceedings of the National Academy of Sciences, 1989
- Selective loss of beta 2-microglobulin mRNA in human colon carcinoma.The Journal of Experimental Medicine, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Evidence for function of Ia molecules on gut epithelial cells in man.The Journal of Experimental Medicine, 1987
- N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastomaCell, 1986
- Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancerInternational Journal of Cancer, 1986
- Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunityNature, 1983
- EXPRESSION OF Ia-LIKE ANTIGENS IN NORMAL HUMAN NONLYMPHOID TISSUESTransplantation, 1981